MedPath
HSA Approval

NARATRIPTAN FILM-COATED TABLETS 2.5MG

SIN14787P

NARATRIPTAN FILM-COATED TABLETS 2.5MG

NARATRIPTAN FILM-COATED TABLETS 2.5MG

May 22, 2015

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantMEDICELL PHARMACEUTICAL (S) PTE. LTD.
Licence HolderMEDICELL PHARMACEUTICAL (S) PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

TABLET, FILM COATED

ORAL

Medical Information

N02CC02

naratriptan

Manufacturer Information

MEDICELL PHARMACEUTICAL (S) PTE. LTD.

Chanelle Medical Unlimited Company

Active Ingredients

Naratriptan Hydrochloride 2.78mg eqv Naratriptan

2.50mg

Naratriptan

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.